Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Head & Neck 1Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Ovarian Neoplasms 14Uterine Cervical Neoplasms 6Breast Neoplasms 5Melanoma 4Fallopian Tube Neoplasms 4Carcinoma, Ovarian Epithelial 4Vaginal Neoplasms 3Neoplasm Metastasis 3Esophageal Neoplasms 3Stomach Neoplasms 2Penile Neoplasms 2Papillomavirus Infections 2Pancreatic Neoplasms 2Oropharyngeal Neoplasms 2Lung Neoplasms 2Kidney Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Anus Neoplasms 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Recurrence 1Rectal Neoplasms 1Neoplasms 1Mesothelioma 1

Interventions

Cyclophosphamide 6fludarabine 4Doxorubicin 4Ifosfamide 3Injections 2Imatinib Mesylate 2Filgrastim 2perifosine 1fludarabine phosphate 1brostallicin 1aldesleukin 1Trabectedin 1Temozolomide 1Sunitinib 1Radiotherapy 1Radiation 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Mass Spectrometry 1Leukapheresis 1Interleukin-2 1Immunotherapy, Adoptive 1Immunotherapy 1Drug Therapy 1Decitabine 1Chromatography, High Pressure Liquid 1Chemotherapy, Adjuvant 1Biological Therapy 1BI 2536 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Synovial × fludarabine phosphate × Gynecologic × Clear all
NCT02366546 2018-10-24

Investigator Initiated Phase 1 Study of TBI-1301

Mie University

Phase 1 Unknown
9 enrolled
DermatologicGastrointestinalGynecologicHead & NeckSarcoma

Esophageal Neoplasms, Head and Neck Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡